从初始处方开始的2年内,对拉斯米迪坦治疗模式进行时间序列聚类分析
Masahito Katsuki1,2, Yuya Yamada3, Taisuke Ichihara3
1Insight Science Foundation Ireland Research Centre for Data Analytics, School of Human and Health Performance, Dublin City University, Dublin, Ireland.
Therapeutic advances in neurological disorders
|October 14, 2025
概括
这项研究分析了日本的拉斯米迪坦处方模式,在两年内揭示了三种不同的患者使用轨迹. 结果突出了多种长期使用,包括持续治疗和早期停药,为偏头痛治疗策略提供了信息.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 偏头痛是一种常见的神经疾病,是全球导致残疾的主要原因.
- 目前的治疗方法,如三药和NSAIDs对一些患者有局限性.
- 拉斯米迪坦是一种5-HT1F受体激动剂,提供了一个没有血管收缩作用的新选择,适合心血管风险患者.
研究的目的:
- 为了检查在日本的拉斯米迪坦的2年现实世界处方模式.
- 根据使用时间序列聚类的拉斯米迪坦使用轨迹来识别不同的患者子组.
主要方法:
- 一项追溯观察性研究利用了日本全国范围的医疗保险索赔数据.
- 分析了从2022年1月到2024年12月被诊断患有偏头痛的15岁以上患者 (ICD-10:G43) 的数据.
- 处方声明在90天间隔分析了长达24个月的时间,应用时间序列聚类来确定使用模式.
主要成果:
- 在167,461名偏头痛患者中,拉斯米迪坦被处方给了12.7%的患者.
- 最初的处方偏好50mg,常见的是组合治疗,包括止痛药,三药和预防药物.
- 时间序列聚类确定了三个不同的使用组:连续使用,逐渐缩小和早期停止.
结论:
- 这项研究提供了第一个关于拉斯米迪坦长期处方模式的现实证据.
- 三种不同的使用轨迹凸显了临床实践中的异质性.
- 需要对拉斯米迪坦最佳使用进行进一步的研究,特别是关于组合疗法和潜在的药物过量使用.
更多相关视频
相关概念视频
Pulmonary Tuberculosis V
534
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
534
Drug Concentration Versus Time Correlation
2.0K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
2.0K
Time Course of Drug Effect
2.6K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.6K
Actuarial Approach
286
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
286
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
232
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
232
Dosage Regimen: Multiple Oral Dosage
229
Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
229


